Navigation Links
Former Stryker CEO Takes Reins at sBioMed
Date:11/1/2012

OREM, Utah, Nov. 1, 2012 /PRNewswire/ -- sBioMed, an emerging leader in infection control, announced today that Stephen P. MacMillan, former Chairman and CEO of Stryker, has joined the company as Chief Executive Officer and become an owner of the company.

sBioMed has developed breakthrough patented antimicrobial technologies, offering an unprecedented level of efficacy and safety. The company's flagship product STERIPLEX SD is the first and only Clostridium difficile sporicide and broad-spectrum, one-step disinfectant, which is also remarkably safe, completely non-fuming, non-corrosive, and contains no bleach.

The technology is similar to the company's anthrax remediation product, STERIPLEX Ultra, the only EPA-registered product available that kills anthrax spores.

Brian Larson, sBioMed's cofounder and chairman, said, "After a decade of research, over 500 studies and EPA-registration, we are excited to enter the full-scale commercialization process.  With Steve's leadership, we can help eliminate Healthcare-Associated Infections (HAIs) globally."

"It's rare to find a product with such revolutionary potential," MacMillan said. "STERIPLEX SD will save lives, improve healthcare delivery and protect caregivers, while reducing healthcare costs and preserving the environment.  I'm also excited about the chance to work with the sBioMed team to build a very special global company based in Utah."

With the growing incidence of C. diff and other superbugs, infections are now the fourth leading killer in the U.S., at a cost to the U.S. healthcare system of tens of billions of dollars annually.  Effective January 1, 2013, costs associated with HAIs will no longer be reimbursed, giving hospitals a strong incentive to eliminate HAIs. Hospitals currently employing STERIPLEX SD have charted a significant drop in HAIs.

STERIPLEX SD is EPA-registered for use on food contact surfaces (NSF D2) and can even be used
'/>"/>

SOURCE sBioMed
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
2. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PharmaVentures Helps Secure Investor for Former MSD Research Site
5. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
6. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
7. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
8. New Kit Takes the Uncertainty Out of Lymphoma Diagnosis
9. Terminator-style info-vision takes step towards reality
10. Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
11. Quammen Health Care Consultants Takes Over Information Technology Reins at Faith Regional Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , "The interface is the device," Nobel laureate ... properties to be found at the junctures where ... world of nanotechnology, the interfaces between layers of ... in such high-tech favorites as spintronics, high-temperature superconductors, ...
(Date:1/15/2014)... January 15, 2014 Cynvenio, a cancer ... through the genomic analysis of tumor cells in the ... a web-based cancer decision support application powered by CollabRx, ... Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast ...
(Date:1/15/2014)... More than 5 million Americans are currently living ... will die with Alzheimer’s or another dementia, according to ... many Americans into looking for ways to improve their ... cognitive disorders. Jonathan Weisman, president of Biohack Pure, is ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
Breaking Biology Technology:A deeper look at interfaces 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3
... , Latest Trends and Research ... Biotech Industry Scientists , , NEW ... Discovery, hosted by the Alzheimer,s Drug Discovery Foundation ... and development of innovative drugs targeting Alzheimer,s disease and related dementias, ...
... September 1 , - ... Suggesting the Need to Reconsider Approach to Management of,Lipids ... initiative (R3i) Foundation Presents Early,Findings From Unique Global Investigation ... Low levels of high-density lipoprotein cholesterol ...
... , , , , ... NVAX ) announced today favorable results from a Phase II ... vaccine candidate. The vaccine was well tolerated and induced robust ... These results continue to support the planned study in elderly adults ...
Cached Biology Technology:Alzheimer's Drug Discovery Foundation Hosts 10th International Conference on Alzheimer's Drug Discovery - September 14-15 2Alzheimer's Drug Discovery Foundation Hosts 10th International Conference on Alzheimer's Drug Discovery - September 14-15 3New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 2New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 3New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 4New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 5New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 6New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 7New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 8NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 4NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 5
(Date:7/9/2014)... A new study shows that some shark species may be ... that may come with rising temperatures. , The Arctic today ... but it wasn,t always like that. Roughly 53 to 38 ... epoch, the Arctic was more similar to a huge temperate ... life, including ancestors of tapirs, hippo-like creatures, crocodiles and giant ...
(Date:7/9/2014)... penguins shows that the population is 3.79 million ... estimated. Adlie penguins have long been considered a ... effects of climate change and fishing in the ... researchers from Stony Brook University and University of ... regular monitoring of Adlie penguins across their entire ...
(Date:7/9/2014)... is one of the amphibians with the highest distribution ... areas of water where it comes into contact with ... Research carried out by the Spaniard Germn Orizaola from ... of these frogs have developed a defensive response to ... larger bodies if they co-exist with the crayfish. , ...
Breaking Biology News(10 mins):Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3
... NEW YORK An article released today ... Associated with Illegally Imported Wildlife Products, from a ... Disease Control and Prevention (CDC), identified evidence of ... confiscated at several U.S. international airports, including John ...
... of California, San Francisco (UCSF) has signed an alliance ... SNY) to share expertise in diabetes research and identify ... both type 1 and type 2 diabetes. The ... UCSF labs with deep understanding of the biology of ...
... limited and their combustion in vehicle motors increases atmospheric ... as an alternative is on the rise. In the ... his team at the Technische Universitaet Muenchen have now ... conversion of biopetroleum from microalgae into diesel fuels. ...
Cached Biology News:Study establishes importance of tracking diseases associated with illegal wildlife trade 2Study establishes importance of tracking diseases associated with illegal wildlife trade 3UCSF, Sanofi collaborate to find new diabetes cures 2UCSF, Sanofi collaborate to find new diabetes cures 3Algae for your fuel tank 2
AM100 is an aqueous-based, permanent mounting media designed for use with alkaline phosphatase and immunoperoxidase stained tissue sections....
...
... Fixation Buffer, used in conjunction with ... can be used to fix and ... staining of cytokines and other cytoplasmic ... been specially formulated for reducing non-specific ...
... polyclonal to JMJD2D ( Abpromise for ... Synthetic peptide conjugated to KLH derived ... Human JMJD2D.(Note: the amino acid sequence is ... Entrez Gene ID: 55693 ...
Biology Products: